These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 12484506

  • 1. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
    Sato A, Hayashi M, Saruta T.
    Hypertens Res; 2002 Nov; 25(6):837-42. PubMed ID: 12484506
    [Abstract] [Full Text] [Related]

  • 2. High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients.
    Sato A, Takane H, Saruta T.
    Hypertens Res; 2001 Mar; 24(2):99-104. PubMed ID: 11325081
    [Abstract] [Full Text] [Related]

  • 3. Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.
    Sato A, Suzuki Y, Saruta T.
    Hypertens Res; 1999 Mar; 22(1):17-22. PubMed ID: 10221346
    [Abstract] [Full Text] [Related]

  • 4. A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome.
    Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, O'Moore-Sullivan T, Marwick TH.
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1239-49. PubMed ID: 22172779
    [Abstract] [Full Text] [Related]

  • 5. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M, Oki T, Iuchi A, Tabata T, Yamada H, Manabe K, Fukuda K, Abe M, Ito S.
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [Abstract] [Full Text] [Related]

  • 6. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients.
    Sasaguri M, Noda K, Tashiro E, Notomo J, Tsuji E, Koga M, Arakawa K.
    Hypertens Res; 2000 Jul; 23(4):317-22. PubMed ID: 10912767
    [Abstract] [Full Text] [Related]

  • 7. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH.
    Circulation; 2003 Oct 14; 108(15):1831-8. PubMed ID: 14517164
    [Abstract] [Full Text] [Related]

  • 8. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.
    Gupta A, Schiros CG, Gaddam KK, Aban I, Denney TS, Lloyd SG, Oparil S, Dell'Italia LJ, Calhoun DA, Gupta H.
    J Hum Hypertens; 2015 Apr 14; 29(4):241-6. PubMed ID: 25231508
    [Abstract] [Full Text] [Related]

  • 9. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Apr 14; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug 14; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 11. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H.
    Nephrol Dial Transplant; 2013 Jul 14; 28(7):1787-93. PubMed ID: 23378418
    [Abstract] [Full Text] [Related]

  • 12. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW.
    Nephrol Dial Transplant; 1999 May 14; 14(5):1113-6. PubMed ID: 10344347
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 14; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 14. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B, Nalbantgil S, Yilmaz H, Zoghi M, Ozerkan F, Nalbantgil I, Onder R.
    Saudi Med J; 2004 Dec 14; 25(12):1975-8. PubMed ID: 15711679
    [Abstract] [Full Text] [Related]

  • 15. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M, Yokokawa K, Minami M, Kano H, Yasunari K, Hanehira T, Yoshikawa J.
    Am J Med; 1999 May 14; 106(5):544-9. PubMed ID: 10335726
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide.
    Nakahara T, Takata Y, Hirayama Y, Asano K, Adachi H, Shiokawa G, Sumi T, Ogawa T, Yamashina A.
    Circ J; 2007 May 14; 71(5):716-21. PubMed ID: 17456997
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B.
    Blood Press Suppl; 1994 May 14; 2():35-40. PubMed ID: 8061844
    [Abstract] [Full Text] [Related]

  • 18. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy.
    Kohno M, Minami M, Kano H, Yasunari K, Maeda K, Hanehira T, Yoshikawa J.
    Metabolism; 2000 Oct 14; 49(10):1356-60. PubMed ID: 11079829
    [Abstract] [Full Text] [Related]

  • 19. [Chronic effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor enalapril on circulating procollagen marker P III NP and vascular resistance in patients with essential hypertension].
    Ren YH, Liu YQ, Gai LY, Yang TS, Li TD.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun 14; 34(6):508-11. PubMed ID: 16842666
    [Abstract] [Full Text] [Related]

  • 20. Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
    Azizi M, Perdrix L, Bobrie G, Frank M, Chatellier G, Ménard J, Plouin PF.
    J Hypertens; 2014 Oct 14; 32(10):2038-44; discussion 2044. PubMed ID: 24983187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.